BioSpace News Archive

BioPrax is a minimally invasive and cost-effective device that is under investigation to help eliminate biofilm infections on prosthetic knee implants during early intervention procedures, while also maintaining the current standard of care.

Health Gorilla, a leader in clinical data APIs, and WellVia, a premier telehealth company, announced today a partnership that enables new data exchange capabilities within the WellVia telehealth platform.

SignalPath, a healthcare technology company reimagining the execution of clinical trials, announces the closing of their Series B funding round of $18M.

Amendola Communications, a nationally recognized, award-winning healthcare and health IT public relations and marketing firm, announced that TAGNOS has hired the agency to provide strategic PR and content marketing services.

Endodontist survey also finds majority unable to identify safest Halloween candies for teeth

Tishcon Corp., a leading manufacturer and marketer of vitamins, dietary and herbal supplements has announced that the results of an independent study on the efficacy of the company’s Freedom Softgels® in treating hypertension and chronic inflammation will be published by Clinical Nutrition, the peer-reviewed publication of the European Society for Clinical Nutrition and Metabolism.

Seasoned industry finance executive to help guide Oncorus as it advances toward the clinic and progresses next-generation viral immunotherapies

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent notification received from FINRA after-market that they have decided to continue their review.

Revolution Medicines, Inc., a clinical-stage oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced that preclinical in vivo data on the company’s novel inhibitors of oncogenic RAS(ON) mutants will be presented at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today announces the execution of supply agreements with Celgene Corporation for the automation of certain engineered T cell manufacturing processes.